Core Insights - The event during the China International Import Expo focused on the importance of public awareness and prevention of chronic kidney diseases, particularly IgA nephropathy, which is a significant health concern in China [1][5] - The World Health Organization has classified chronic kidney disease as a major non-communicable disease that requires urgent attention [1] - The discussion highlighted the need for improved diagnosis, treatment awareness, and long-term management strategies for IgA nephropathy patients [2][5] Group 1: Challenges in IgA Nephropathy Management - IgA nephropathy faces three main challenges: timely and accurate diagnosis, insufficient understanding of treatment goals, and difficulties in long-term disease progression management [2] - There is a call for innovative treatment solutions and enhanced public health education to improve patient outcomes and awareness [2][5] Group 2: Role of Education and Awareness - Experts emphasized the necessity of comprehensive public education on kidney health, addressing common misconceptions and promoting accurate information [2][5] - The importance of utilizing authoritative media and new technologies, such as AI, to expand the reach and effectiveness of health education was discussed [5] Group 3: Corporate Responsibility - Companies like Novartis recognize their responsibility in providing high-quality, scientific information to patients and are committed to social responsibility in the kidney disease sector [5]